Implications of Efavirenz Pharmacogenetics When Switching From Efavirenz- to Dolutegravir-containing Antiretroviral Regimens is a research paper published in Clinical Infectious Diseases (2020). On theSindex it has a DataRank of 0.292. It has been cited 6 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.292
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: AI077505
National Institutes of Health
Grant: TR000445
National Institutes of Health
Grant: AI069439
Tennessee Center for AIDS Research
Grant: P30 AI110527
NIAID NIH HHS
Grant: R01 AI077505
NCATS NIH HHS
Grant: UL1 TR000445
NIAID NIH HHS
Grant: U01 AI069439
NIAID NIH HHS
Grant: UM1 AI069439
FWCI
0.10
Citation Percentile
0.5%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals